Table 2.
HCM (n = 48) | Disease candidate (n = 22) | Hypertensive controls (n = 50) | Healthy controls (n = 60) | |
---|---|---|---|---|
Relative apical hypertrophy | 36 (75%) | 22 (100%) | 0 | 0 |
Apex:base wall thickness ratio | 1.2 ± 0.3 | 1.2 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.1 |
LA dilated ≥ 25 mm | 34 (71%) | 15 (68%) | 17 (34%) | 8 (13%) |
Apical obliteration | ||||
> 10 mm | 47 (98%) | 21 (95%) | 10 (20%) | 0 |
> 20 mm | 40 (83%) | 14 (64%) | 0 | 0 |
Apical microaneurysm | 11 (23%) | 3 (14%) | 0 | 0 |
Scar | 33 (67%) | 9 (41%) | 4 (8%) | 0 |